Trial Profile
Phase II trial of AVN 211 in patients with Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2013
Price :
$35
*
At a glance
- Drugs AVN 211 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 25 Jul 2013 New trial record
- 15 Jul 2013 This study is expected to be initiated in 2014, according to an Avineuro Pharmaceuticals media release.